Form 4: Edwards Lifesciences Executive Sells Shares
Insider Transaction (Form 4)
Daveen Chopra, CVP, TMTT, Surgical & IHFM of Edwards Lifesciences Corp, sold 31,800 shares of common stock on August 26, 2026.
Summary
- Option exercise/conversion: acquired 31,800 Common Stock at $72.68 ($2,311,224) on August 26, 2026; holds 76,124 after (Direct).
- Open-market sale: disposed of 1,154 Common Stock at $91.76 ($105,893) on August 26, 2026; holds 74,970 after (Direct).
- Open-market sale: disposed of 30,646 Common Stock at $90.99 ($2,788,547) on August 26, 2026; holds 44,324 after (Direct).
- Option exercise/conversion: disposed of 31,800 Employee Stock Option (Right to Acquire) on August 26, 2026 (Direct).
Sentiment
Score: 3
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $2,894,440 of stock on the open market.
Insider Transactions
Daveen Chopra — Officer (CVP, TMTT, Surgical & IHFM)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-26 | Option exercise/conversion | Common Stock | 31,800 | $73 | $2.3M | 76,124 |
| 2026-08-26 | Open-market sale | Common Stock | 1,154 | $92 | $105.9K | 74,970 |
| 2026-08-26 | Open-market sale | Common Stock | 30,646 | $91 | $2.8M | 44,324 |
| 2026-08-26 | Option exercise/conversion | Employee Stock Option (Right to Acquire) | 31,800 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-26 | Option exercise/conversion (31,800 shares) |
| 2026-08-26 | Open-market sale (1,154 shares) |
| 2026-08-26 | Open-market sale (30,646 shares) |
| 2026-08-26 | Option exercise/conversion (31,800 shares) |
Keywords
insider transaction, Form 4, EW, Edwards Lifesciences Corp, bearish, Daveen Chopra
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.